Lan V. Pham

2.9k total citations
57 papers, 1.7k citations indexed

About

Lan V. Pham is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Lan V. Pham has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pathology and Forensic Medicine, 23 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Lan V. Pham's work include Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Immune Cell Function and Interaction (13 papers). Lan V. Pham is often cited by papers focused on Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Immune Cell Function and Interaction (13 papers). Lan V. Pham collaborates with scholars based in United States, China and Ireland. Lan V. Pham's co-authors include R. Ford, Archito T. Tamayo, Linda C. Yoshimura, Piao Lo, Yen-Chiu Lin-Lee, Lingchen Fu, Michael Wang, L. Jeffrey Medeiros, Changping Li and Ken H. Young and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Immunity.

In The Last Decade

Lan V. Pham

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan V. Pham United States 23 822 583 580 556 389 57 1.7k
Shao Ning Yang United States 17 816 1.0× 451 0.8× 380 0.7× 514 0.9× 213 0.5× 26 1.5k
Archito T. Tamayo United States 16 631 0.8× 413 0.7× 393 0.7× 412 0.7× 246 0.6× 34 1.2k
Erin Hertlein United States 20 774 0.9× 551 0.9× 517 0.9× 272 0.5× 768 2.0× 48 1.7k
Marc A. Weniger United States 18 670 0.8× 366 0.6× 750 1.3× 605 1.1× 349 0.9× 34 1.6k
Ingo Ringshausen Germany 21 1.0k 1.3× 335 0.6× 387 0.7× 739 1.3× 611 1.6× 47 1.8k
Jonathan H. Schatz United States 18 614 0.7× 494 0.8× 413 0.7× 505 0.9× 199 0.5× 74 1.5k
Ellen Leich Germany 23 606 0.7× 217 0.4× 546 0.9× 557 1.0× 287 0.7× 50 1.4k
Florence Ajchenbaum‐Cymbalista France 23 550 0.7× 612 1.0× 670 1.2× 575 1.0× 909 2.3× 40 1.7k
Lixin Rui United States 19 724 0.9× 986 1.7× 290 0.5× 374 0.7× 169 0.4× 37 1.9k
Stefania Gobessi Italy 17 704 0.9× 753 1.3× 499 0.9× 245 0.4× 959 2.5× 34 1.6k

Countries citing papers authored by Lan V. Pham

Since Specialization
Citations

This map shows the geographic impact of Lan V. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan V. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan V. Pham more than expected).

Fields of papers citing papers by Lan V. Pham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan V. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan V. Pham. The network helps show where Lan V. Pham may publish in the future.

Co-authorship network of co-authors of Lan V. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Lan V. Pham. A scholar is included among the top collaborators of Lan V. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan V. Pham. Lan V. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deng, Manman, Ziying Fan, Lan V. Pham, et al.. (2023). The synergy of the XPO1 inhibitors combined with the BET inhibitor INCB057643 in high-grade B-cell lymphoma via downregulation of MYC expression. Scientific Reports. 13(1). 18554–18554. 4 indexed citations
2.
Shi, Yuanfei, Qiulin Chen, Lan V. Pham, et al.. (2021). CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With MYC and BCL2 Rearrangements. Frontiers in Oncology. 11. 618908–618908. 4 indexed citations
3.
Y, Liu, Nancy G. Azizian, Yaling Dou, Lan V. Pham, & Yulin Li. (2019). Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma. Journal of Hematology & Oncology. 12(1). 119–119. 16 indexed citations
4.
Gu, Yong, Shanshan Pei, Peng Yu, et al.. (2019). Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE). Journal of Autoimmunity. 102. 77–88. 45 indexed citations
5.
Pham, Lan V., et al.. (2019). Three Perspectives on Canterbury Freshwater Management. Policy Quarterly. 15(3). 2 indexed citations
6.
Pham, Lan V., Shengjian Huang, Hui Zhang, et al.. (2018). Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas. Clinical Cancer Research. 24(16). 3967–3980. 63 indexed citations
7.
Pham, Lan V., et al.. (2018). The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas. Frontiers in Oncology. 8. 147–147. 33 indexed citations
8.
Pham, Lan V., Gary Lu, Archito T. Tamayo, et al.. (2015). Establishment and characterization of a novel MYC/BCL2 “double-hit” diffuse large B cell lymphoma cell line, RC. Journal of Hematology & Oncology. 8(1). 121–121. 9 indexed citations
9.
10.
Zhang, Liang, Lan V. Pham, Kate J. Newberry, et al.. (2013). In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome. Molecular Cancer Therapeutics. 12(11). 2494–2504. 22 indexed citations
11.
12.
Ou, Zhishuo, Lan V. Pham, Liang Zhang, et al.. (2013). Targeting BCR Activated STAT3 By Ibrutinib In Mantle Cell Lymphoma. Blood. 122(21). 3079–3079. 5 indexed citations
13.
Lyu, Mi-Ae, Lan V. Pham, Bokyung Sung, et al.. (2012). The therapeutic effects of rGel/BLyS fusion toxin in in vitro and in vivo models of mantle cell lymphoma. Biochemical Pharmacology. 84(4). 451–458. 4 indexed citations
14.
Wang, Michael, Archito T. Tamayo, Sharon Shacham, et al.. (2012). Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma. Experimental Hematology. 41(1). 67–78.e4. 82 indexed citations
15.
Pham, Lan V., Archito T. Tamayo, Changping Li, et al.. (2010). Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo : Therapeutic Implications. Molecular Cancer Therapeutics. 9(7). 2026–2036. 46 indexed citations
16.
Vega, Francisco, Jeong Hee Cho‐Vega, Shuguang Ma, et al.. (2009). Side population of a murine mantle cell lymphoma model contains tumour‐initiating cells responsible for lymphoma maintenance and dissemination. Journal of Cellular and Molecular Medicine. 14(6b). 1532–1545. 14 indexed citations
17.
Pham, Lan V., Haijun Zhou, Yen-Chiu Lin-Lee, et al.. (2007). Nuclear Tumor Necrosis Factor Receptor-associated Factor 6 in Lymphoid Cells Negatively Regulates c-Myb-mediated Transactivation through Small Ubiquitin-related Modifier-1 Modification. Journal of Biological Chemistry. 283(8). 5081–5089. 24 indexed citations
18.
Lin-Lee, Yen-Chiu, Lan V. Pham, Archito T. Tamayo, et al.. (2006). Nuclear Localization in the Biology of the CD40 Receptor in Normal and Neoplastic Human B Lymphocytes. Journal of Biological Chemistry. 281(27). 18878–18887. 43 indexed citations
19.
Rangel, Roberto, Eric Wieder, Jeffrey J. Molldrem, et al.. (2005). Assembly of the κ PreB Receptor Requires a Vκ-like Protein Encoded by a Germline Transcript. Journal of Biological Chemistry. 280(18). 17807–17814. 8 indexed citations
20.
Pham, Lan V., Archito T. Tamayo, Linda C. Yoshimura, Piao Lo, & R. Ford. (2003). Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis. The Journal of Immunology. 171(1). 88–95. 266 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shao Ning Yang Breakdown of academic impact, for papers by Archito T. Tamayo Breakdown of academic impact, for papers by Erin Hertlein Breakdown of academic impact, for papers by Marc A. Weniger Breakdown of academic impact, for papers by Ingo Ringshausen Breakdown of academic impact, for papers by Jonathan H. Schatz Breakdown of academic impact, for papers by Ellen Leich Breakdown of academic impact, for papers by Florence Ajchenbaum‐Cymbalista Breakdown of academic impact, for papers by Lixin Rui Breakdown of academic impact, for papers by Stefania Gobessi
Rankless by CCL
2026